Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of generic etoricoxib 120 mg vs ARCOXIA in healthy Thai volunteers under fasting
TCTR20200428003Phase 1Not yet recruiting
- Sponsor
- Novell Pharmaceutical Laboratories
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of etoricoxib in pain, chronic pain, osteoarthritis (OA) and 3 more (2 arms), sponsored by Novell Pharmaceutical Laboratories. Planned start May 2020; status: not yet recruiting.
02
Drugs
etoricoxib
03
Conditions
painchronic painosteoarthritis (OA)rheumatoid arthritis (RA)ankylosing spondylitis (AS)
Beyond the preview
Go deeper on TCTR20200428003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20200428003.